Short- and Long-term Treatment of Pyridoxamine, an Inhibitor of Advanced Glycation End Products, Attenuates Plateletneutrophil Interactions and Vascular Occlusion in Sickle Cell Disease

被引：0
|
作者：
Li, Jing
Jeong, Si-Yeon
Xiong, Bei
Tseng, Alan
Mahon, Andrew
Isaacman, Steven
Cho, Jaehyung
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A285
引用
收藏
页数：2
相关论文
共 9 条
  • [1] Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome
    Diamanti-Kandarakis, Evanthia
    Katsikis, Ilias
    Piperi, Christina
    Alexandraki, Krystallenia
    Panidis, Dimitrios
    CLINICAL ENDOCRINOLOGY, 2007, 66 (01) : 103 - 109
  • [2] Lack of Receptor of Advanced Glycation End Products (RAGE) Attenuates Long-Term Cigarette Smoke Exposure-Induced Vascular Dysfunction in C57BL6 Mice
    Sun, Chang
    Layec, Gwenael
    Guerrero, Maria
    Huecksteadt, Thomas
    Sanders, Karl
    Joidal, John
    Richardson, Russell
    Kwon, Oh
    FASEB JOURNAL, 2020, 34
  • [3] Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinoma
    Procopio, Giuseppe
    Sabbatini, Roberto
    Porta, Camillo
    Verzoni, Elena
    Galligioni, Enzo
    Ortega, Cinzia
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (08) : 1089 - 1096
  • [4] Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1
    Cozzolino, D
    Coppola, L
    Masi, S
    Salvatore, T
    Sasso, FC
    De Lucia, D
    Gentile, S
    Torella, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (07) : 491 - 497
  • [5] Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1
    D. Cozzolino
    L. Coppola
    S. Masi
    T. Salvatore
    F. C. Sasso
    D. De Lucia
    S. Gentile
    R. Torella
    European Journal of Clinical Pharmacology, 1999, 55 : 491 - 497
  • [6] Long-Term L-Glutamine Treatment Reduces Hemolysis without Ameliorating Hepatic Vaso-Occlusion and Liver Fibrosis in a Mouse Model of Sickle Cell Disease
    Katoch, Omika
    Ungalara, Ramakrishna
    Kaminski, Tomasz
    Li, Ziming
    Dubey, Rikesh K.
    Burholt, Isabella
    Gudapati, Shweta
    Pradhan-Sundd, Tirthadipa
    BIOMEDICINES, 2023, 11 (09)
  • [7] Short- and long-term follow-up and additional benefits in a sickle cell disease patient experienced severe crizanlizumab infusion-related vaso-occlusive crisis: A case report
    Alshurafa, Awni
    Yassin, Mohamed A.
    FRONTIERS IN MEDICINE, 2022, 9
  • [8] Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up
    Szabo, Gabor Viktor
    Koevesd, Zsuzsa
    Cserepes, Judit
    Daroczy, Judit
    Belkin, Michael
    Acsady, Gyoergy
    CYTOTHERAPY, 2013, 15 (10) : 1245 - 1252
  • [9] Treatment with IMR-687, a Highly Selective PDE9 Inhibitor, Increases HbF and Reduces VOCs in Adults with Sickle Cell Disease in a Long-Term, Phase 2a, Open-Label Extension Study
    Andemariam, Biree
    Mant, Timothy
    Eleftheriou, Perla
    Lugthart, Sanne
    Bronte-Hall, Lanetta
    Barroso, Filipa
    Blyden, Gershwin
    Mason, James
    Barysauskas, Constance M.
    Yen, Joseph
    Tang, Karen
    Ballal, Rahul
    Attie, Kenneth
    BLOOD, 2021, 138
1